Medicenna Therapeutics Corp Financial Overview
Medicenna Therapeutics Corp's market cap is currently $50.52M. The company's EPS TTM is $-0.04349604; its P/E ratio is -5.87; Medicenna Therapeutics Corp is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
